Alex Parks – CEO and Managing Director – Prominence Energy (ASX:PRM) is an ASX listed oil and gas exploration and development company.
Copyright 2023 – Finance News Network
01 Dec 2021 - MinRex Resources Limited (ASX:MRR) Non-Executive Director George Karageorge provides an update on the company's gold and base metals projects in WA and the Lachlan Ford Belt, NSW and its recently acquired lithium projects in the Pilbara.
21 Mar 2023 - Centuria Capital Group Limited (ASX:CNI) Joint CEO John McBain discusses the rising interest rate environment, the company's expansion into the healthcare and agricultural sectors, the acquisition of Primewest, and possible future M&A opportunities.
30 Nov 2021 - Chimeric Therapeutics Limited (ASX:CHM) CEO and Managing Director Jennifer Chow talks about the recent presentation of data from the CHM 1101 (Chlorotoxin CAR T) Phase 1 clinical trial in glioblastoma patients.
09 Mar 2020 - Lithium Power International Limited (ASX:LPI) Managing Director and CEO Cristobal Garcia-Huidobro and Executive Director and CFO Andrew Phillips discuss the Environmental Approval for the company's Maricunga lithium brine project in Northern Chile, what this means for the project, and what’s planned.
26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.
29 Jan 2021 - Cyclopharm (ASX:CYC) CEO & Managing Director, James McBrayer talks about its recent cap raising to support rapid USA commercialisation for Technegas following USFDA approval targeted in Q2 2021.
23 Nov 2021 - WT Financial Group Limited (ASX:WTL) Founder and Managing Director Keith Cullen provides an introduction to the company's range of services to wholesale and retail clients.
08 Dec 2021 - Altech Chemicals Limited (ASX:ATC) Managing Director Iggy Tan discusses the cracking of the "silicon barrier" in order to significantly increase the energy retention and capacity of lithium-ion batteries for electric vehicles.
03 Nov 2022 - Antisense Therapeutics Limited (ASX:ANP) Chair, Dr Charmaine Gittleson, and new Chief Commercial Officer, Dr Anthony Filippis, discuss Antisense's progress, attracting new talent to the company, and what drew Dr Filippis to the role.